A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Anterior Uveitis
Stopped early · Phase 2/Phase 3
Conditions studied: Anterior Uveitis
In brief
This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone for the treatment of non-infectious anterior uveitis.
Key facts
- Study ID
- NCT00333996
- Run by
- Allergan
- People needed
- 5
- Starts
- 2006-05-01
- Expected to finish
- 2007-03-01
- Last updated by the study team
- 2011-05-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 18 years or older with a diagnosis of non-infectious anterior uveitis in at least one eye
You may not qualify if…
- Uncontrolled systemic disease
- Any active ocular infections
Where it is running
- Study site — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.